Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 11;21(3):69-72.
doi: 10.1097/CLD.0000000000000020. eCollection 2023 Mar.

In a tight spot

Eric M Przybyszewski  1 , Daniel S Pratt  1   2
Affiliations

In a tight spot

Eric M Przybyszewski et al. Clin Liver Dis (Hoboken). .

Abstract

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts to report.

Figures

None
Graphical abstract
FIGURE 1
FIGURE 1
MRCP (A) and ERCP with extrahepatic (B) and intrahepatic (C) cholangiogram for evaluation of primary sclerosing cholangitis with a dominant stricture. There is irregular narrowing of intrahepatic bile ducts and dominant stricture of the distal CBD (yellow arrows). Abbreviation: CBD, common bile duct; ERCP, endoscopic retrograde cholangiopancreatography; MRCP, magnetic resonance cholangiopancreatography.
FIGURE 2
FIGURE 2
Cholangiocarcinoma surveillance in primary sclerosing cholangitis. Abbreviation: CBD, common bile duct; ERCP, endoscopic retrograde cholangiopancreatography; FISH, fluorescent in situ hybridization; MRCP, magnetic resonance cholangiopancreatography; PSC, primary sclerosing cholangitis.
See this image and copyright information in PMC

References

    1. Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BWM, Poen AC, et al. . Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58:2045–2055. - PubMed
    1. Chapman MH, Webster GJ, Bannoo S, Johnson GJ, Wittmann J, Pereira SP. Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience. Eur J Gastroenterol Hepatol. 2012;24:1051–1058. - PMC - PubMed
    1. Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, et al. . Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology. 2017;152:1975–1984.e8. - PMC - PubMed
    1. Deneau MR, El‐Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, et al. . The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology. 2017;66:518–527. - PubMed
    1. Bowlus CL, Lim JK, Lindor KD. AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: Expert Review. Clin Gastroenterol Hepatol. 2019;17:2416–2422. - PubMed